The fund of funds（FOFs）is the core business of The Beijing E-Town International Investment & Development Co. (E-Town Capital for short) . It is managed by its subsidiary -- Beijing E-Town International Industrial Investment Management Co.

The fund has developed rapidly since its establishment in 2013 through guiding social capital to invest in equity market and enabling the financial funds to play the roles of lever and amplifier.

By the end of January 2021, the E-town Capital's FOFs had been participated in the establishment of over 71 funds worth 648 billion yuan ($100.38 billion).

The new generation of information technology, new energy smart automobile, biotechnology, big health, robots and intelligent manufacturing are the main  investment hot spots for its FOF.

The FOFs of E-town Capital has joined in about 1,000 investment projects through market-oriented quality funds, which involve a group of influential enterprises, including Semiconductor Manufacturing International Corporation, GigaDevice, a provider of advanced memory technology and IC solutions, Chipone Technology, Will Semiconductor, GOODiX Technology,  fingerprint sensor solutions provider Vkansee,  Megvii Technology, Farasis Energy, Ronbay Technology, Cambricon, Biotech Pharma, Annoroad  Gene Technology, car rental company Shenzhou Zhuanche, China's largest on-demand services provider Meituan-Dianping, and the car-hailing platform Didi Dache.

One of them, Science Sun Pharma, founded in 1999 with with the stock code of 300485, is a high-tech enterprises specializing in the R&D, production, and sales of biopharmaceutical products (Active protease, active polypeptide, active polysaccharide, amphoteric lipids).

Its research and development focuses on the drugs for cardiovascular and cerebrovascular diseases, immunomodulation (anti-tumor), nervous system diseases, and bio-polypeptide, new biological materials, diagnosis and treatment management for chronic diseases.

The FOFs of E-town Capital earned six times more than its principal thanks to the investment in Science Sun.

The FOFs earned a rate of return of over 90 percent on its investment on another enterprise, Lepu Medical, which was founded in 1999 with the stock code of 300003.

It has expanded it business in China and 95 countries and regions across the world and generates annual operating revenue of 4.6 billion yuan.

Thanks to its adherence to technological innovation, focus on high quality and a path featuring cooperation and win-win results, Lepu is striving to build a full-chain player in the cardiovascular medical industry.

The FOFs of E-Town Capital was placed the first among 2016 Chinese government guided funds

by the China FOFs Alliance and ranked among the Top 10 of both 2016 Chinese Funds of Funds and 2016 Chinese Buyout Funds by Beijing Private Equity Association.

In 2017, it was ranked the Best Top 10 FOFs of China, China’s Best Government-Guided Fund by magazine Chinese Venture, Top 20 Limited Partners in China's Private Equity Market by pedaily.cn.

In 2018, the FOFs won the CLPA LP100 Case Award and dozens of awards such as Top 20 FOF with most concern by GP in China, and  the Golden Bull Industry-Guided Fund Award. 

It has gained good cooperation opportunities with leading organizations in various vertical industries, and its business model has been recognized by a large number of peers.